Intranasal administration of the growth-compromised HSV-2 vector DeltaRR prevents kainate-induced seizures and neuronal loss in rats and mice.

Source:http://linkedlifedata.com/resource/pubmed/id/16500153

Download in:

View as

General Info

PMID
16500153